Description

4-(4-Fluorophenyl)-3-(2-Hydroxy-3,5-Dimethylphenyl)-5-(Pyridin-3-Ylmethyl)-4,5-Dihydropyrrolo[3,4-C]Pyrazol-6(2H)-One is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a key building block in the synthesis of novel therapeutic agents, particularly in medicinal chemistry research and development. It is primarily sought after by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new drug candidates, especially those targeting central nervous system (CNS) disorders and inflammatory pathways.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of potential drug candidates for clinical research.
• Medicinal Chemistry Research: Used as a scaffold or building block for structure-activity relationship (SAR) studies to optimize biological activity and pharmacokinetic properties.
• CNS Drug Development: Applied in the research of new therapeutics for neurological and psychiatric conditions, leveraging its specific molecular architecture.
• Kinase Inhibitor Synthesis: Potential use in the development of selective kinase inhibitors due to the pyrazolopyrrolone core structure.
• Chemical Reference Standard: Supplied as a high-purity standard for analytical method development, validation, and quality control in pharmaceutical analysis.
• Academic & Institutional Research: Utilized in university and institutional labs for fundamental research in organic synthesis and bioorganic chemistry.

Basic Information

Product Name	4-(4-Fluorophenyl)-3-(2-Hydroxy-3,5-Dimethylphenyl)-5-(Pyridin-3-Ylmethyl)-4,5-Dihydropyrrolo[3,4-C]Pyrazol-6(2H)-One
CAS No.	879964-40-6
Molecular Formula	C25H21FN4O2
Molecular Weight	428.46 g/mol
Synonyms	4-(4-Fluorophenyl)-3-(2-hydroxy-3,5-dimethylphenyl)-5-(pyridin-3-ylmethyl)-2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-6-one; 879964-40-6; Pyrrolo[3,4-c]pyrazol-6(2H)-one, 4,5-dihydro-4-(4-fluorophenyl)-3-(2-hydroxy-3,5-dimethylphenyl)-5-(3-pyridinylmethyl)-; 5-(Pyridin-3-ylmethyl)-4-(4-fluorophenyl)-3-(2-hydroxy-3,5-dimethylphenyl)-4,5-dihydro-2H-pyrrolo[3,4-c]pyrazol-6-one
EINECS	Contact for details

Quality Control

Our 4-(4-Fluorophenyl)-3-(2-Hydroxy-3,5-Dimethylphenyl)-5-(Pyridin-3-Ylmethyl)-4,5-Dihydropyrrolo[3,4-C]Pyrazol-6(2H)-One is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the stringent requirements for pharmaceutical R&D applications. Certificates of Analysis (COA) detailing purity, impurities, and other critical parameters are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed to protect from moisture.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.